Skip to Content

Intuitive Surgical Inc ISRG Stock Quote

| Rating as of


Morningstar‘s Stock Analysis ISRG

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Intuitive Surgical Returns to Prepandemic Procedure Demand

Alex Morozov, CFA Regional Director

Business Strategy and Outlook

| Alex Morozov, CFA |

Intuitive Surgical fared remarkably well during the pandemic even as many hospitals struggled with tight capital budgets and elective surgeries were almost nonexistent during the COVID-19 peak. Now, with things returning to normal, the company is set to resume its march toward global adoption of robotic surgery. Our long-term positive view on the company's competitive positioning is unchanged, even as new rivals are entering the previously monopolistic area of robot-assisted surgery.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ISRG

Company Profile ISRG

Business Description

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

1020 Kifer Road
Sunnyvale, CA, 94086-5304
T +1 408 523-2100
Industry Medical Instruments & Supplies
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 9,793

Related News ISRG